SENS - NASDAQ

Senseonics Holdings, Inc.

SENS·NASDAQ

$6.87

-2.2%

HealthcareMedical - Devices

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$286.98M

EPS-1.6600

P/E Ratio-3.33

Earnings Date08/05/2026

126.27M

Assets

26%

3Y-29.0%

5Y+252.0%

10Y+467.0%

65.22M

Total Liabilities

-44%

3Y-64.0%

5Y-64.0%

10Y+140.0%

61.05M

Total Equity

-469%

3Y-2470.0%

5Y-142.0%

10Y-1352.0%

Senseonics Holdings, Inc. Funding & Solvency Profile

SENS · NASDAQ

Current Assets

Cash & Cash Equivalents40.55M

Net Receivables12.43M

Inventory6.70M

Other Current Assets4.37M

Total Current Assets118 M

Non-Current Assets

Property, Plant & Equipment4.20M

Goodwill & Intangible Assets800.00K

Long-Term Investments0.00

Other Non-Current Assets3.74M

Total Non-Current Assets8 M

Total Assets

126.27M

Financial Health Analysis

Current Ratio

4.83x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

1.07x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

93 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

93% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Senseonics Holdings, Inc. Balance Sheet

SENS • NASDAQ

Senseonics Holdings, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	40.5M	74.6M	75.7M	35.8M	33.5M	18M	95.9M	136.8M	16.2M	13M	3.9M	18.9M	10K
Short-Term Investments	53.8M	0.0	33.7M	108.2M	96.4M	0.0	0.0	0.0	20.3M	7.3M	0.0	0.0	0.0
Cash & Short-Term Investments	94M	74.6M	109.5M	144M	129.9M	18M	95.9M	136.8M	36.5M	20.3M	3.9M	18.9M	10K
Net Receivables	12.4M	8.1M	6.6M	2.8M	2.4M	3M	10.5M	7.1M	3.4M	251K	0.0	0.0	0.0
Accounts Receivables	12.1M	6.3M	4.5M	2.5M	2M	3M	10.4M	7.1M	3.4M	251K	0.0	0.0	0.0
Other Receivables	311K	1.8M	2.1M	336K	443K	0.0	107K	0.0	4K	0.0	0.0	0.0	0.0
Inventory	6.7M	4.4M	8.8M	7.3M	6.3M	5.3M	16.9M	10.2M	3M	477K	0.0	0.0	0.0
Prepaids	0.0	4M	5.2M	7.1M	5.7M	3.8M	4.2M	3.6M	2M	223K	1M	711K	0.0
Other Current Assets	4.4M	333K	1K	12K	56K	200K	179K	142K	48K	365K	1M	0.0	0.0
Total Current Assets	117.5M	91.4M	130M	161.2M	144.4M	30.2M	127.8M	158.1M	44.9M	21.4M	5M	19.6M	10K
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	4.2M	3.6M	1.2M	1.1M	1.3M	1.6M	2M	1.8M	853K	735K	311K	182K	387K
Intangible Assets	800K	481.9K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45K	0.0
Goodwill & Intangible Assets	800K	481.9K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45K	0.0
Long-Term Investments	0.0	0.0	0.0	12.3M	51.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	3.7M	4.9M	7M	3.1M	1.3M	4.1M	3M	117K	176K	105K	217K	134K	59K
Total Non-Current Assets	8.7M	9M	8.2M	16.5M	54.5M	5.7M	5M	1.9M	1M	840K	528K	361K	446K
Other Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-446K
Total Assets	126.3M	100.4M	138.2M	177.7M	198.9M	35.9M	132.8M	160M	45.9M	22.3M	5.5M	20M	10K
LIABILITIES
CURRENT LIABILITIES
Total Payables	4.1M	3.2M	4.6M	419K	1.2M	1.8M	4.3M	4.4M	7.7M	3.1M	1.3M	0.0	0.0
Accounts Payable	4.1M	3.2M	4.6M	419K	1.2M	1.8M	4.3M	4.4M	7.7M	3.1M	1.3M	0.0	0.0
Accrued Expenses	0.0	9.3M	7M	9.2M	14.3M	5.7M	10.1M	3.7M	2.2M	1.8M	605K	839K	2.9K
Short Term Debt	0.0	20.1M	0.0	15.6M	2.9M	3.2M	103.8M	10M	10M	3.9M	2.4M	0.0	0.0
Capital Lease Obligations (Current)	496K	429K	368K	725K	904K	794K	696K	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	315K	320K	376K	176K	0.0
Deferred Revenue	0.0	0.0	0.0	0.0	0.0	0.0	0.0	628K	5.2M	4.3M	3.5M	0.0	0.0
Other Current Liabilities	19.8M	5.8M	5.3M	5.5M	-904K	5.1M	7.9M	10.2M	3.2M	2.9M	3.1M	-1.7M	-1.5M
Total Current Liabilities	24.3M	38.8M	17.3M	31.5M	18.4M	16.6M	126.7M	28.9M	23.1M	11.6M	7.3M	2M	2.9K
NON-CURRENT LIABILITIES
Long Term Debt	35.6M	34.7M	41.2M	56.4M	59.8M	57.2M	11.8M	41M	14.4M	15.2M	7.4M	9.8M	0.0
Other Non-Current Liabilities	0.0	37.7M	37.8M	89.7M	305.7M	104.7M	664K	18.9M	1.1M	273K	355K	226K	0.0
Total Non-Current Liabilities	40.9M	78.1M	85.2M	148.8M	366.1M	163.4M	14.7M	59.8M	15.5M	15.5M	7.9M	10M	0.0
Capital Lease Obligations	5.8M	6.2M	6.6M	3.4M	1.5M	2.3M	3M	85K	69K	152K	0.0	0.0	2K
Total Liabilities	65.2M	117M	102.4M	180.2M	384.5M	180M	141.5M	88.7M	38.7M	27.1M	15.2M	12.1M	2.9K
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-84K	0.0
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	237K	183K
Common Stock	41K	595K	530K	480K	447K	266K	203K	177K	137K	94K	76K	2K	10K
Additional Paid-In Capital	1.1B	930.7M	904.5M	806.5M	765.2M	504.2M	464.5M	428.9M	271M	199.8M	151M	138.7M	0.0
Retained Earnings	-1B	-947.9M	-869.3M	-808.9M	-951M	-648.5M	-473.3M	-357.8M	-263.8M	-204.7M	-160.8M	-130.9M	-2.9K
Accumulated Other Comprehensive Income/Loss	69K	0.0	-11K	-678K	-212K	0.0	0.0	-1.3M	-1M	-813K	0.0	-683K	0.0
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-8M	0.0
Total Stockholders' Equity	61M	-16.6M	35.8M	-2.6M	-185.5M	-144.1M	-8.6M	71.3M	7.3M	-4.9M	-9.7M	7.9M	7.1K
Total Equity	61M	-16.6M	35.8M	-2.6M	-185.5M	-144.1M	-8.6M	71.3M	7.3M	-4.9M	-9.7M	7.9M	7.1K
SUMMARY
Total Liabilities & Equity	126.3M	100.4M	138.2M	177.7M	198.9M	35.9M	132.8M	160M	45.9M	22.3M	5.5M	20M	10K
Total Investments	53.8M	0.0	33.7M	120.5M	148.3M	0.0	0.0	0.0	20.3M	7.3M	0.0	0.0	0.0
Total Debt	41.4M	61.1M	47.8M	75.4M	64.2M	62.7M	118.6M	51M	24.5M	19.2M	9.9M	9.8M	0.0
Net Debt	822K	-13.5M	-27.9M	39.6M	30.7M	44.7M	22.6M	-85.8M	8.3M	6.2M	5.9M	-9.1M	-10K
Shares Outstanding	40,851,251	40,851,251	40,851,251	40,851,251	40,851,251	40,851,251	40,851,251	40,851,251	40,851,251	40,851,251	40,851,251	40,851,251	40,851,251

SEC Filings

SENS - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 20, 2026	May 20, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 07, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 07, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 04, 2026	May 01, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 01, 2026	April 30, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 06, 2026	May 20, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 12, 2026	March 12, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 02, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 02, 2026	March 02, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 12, 2026	January 12, 2026	2026	View Filing

Showing 1 to 10 of 225 filings

Related Guides

Blog Categories

Continue your SENS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.